KIMBERLY FRAZE: Open Payments
NPI 1336500768 · FORT WAYNE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,181 in 66 payments from 15 companies in 2025. Trend: 2023 $0 · 2024 $115 · 2025 $1,181
Food & beverage: $1,181
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 12 | $240 |
| E.R. Squibb & Sons, L.L.C. | 10 | $196 |
| Teva Pharmaceuticals USA, Inc. | 7 | $168 |
| ABBVIE INC. | 17 | $150 |
| Alkermes, Inc. | 4 | $105 |
| Lundbeck LLC | 3 | $56 |
| Neurocrine BioSciences, Inc. | 2 | $49 |
| Janssen Pharmaceuticals, Inc | 2 | $48 |
| Otsuka America Pharmaceutical, Inc. | 2 | $39 |
| Collegium Pharmaceutical, Inc. | 2 | $28 |
Products named: CAPLYTA, COBENFY, VRAYLAR, REXULTI, AUSTEDO XR, UZEDY, ARISTADA, LYBALVI.
Industry payments across IN — which companies pay providers there.
